Correlation Between Equillium and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Equillium and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Checkpoint Therapeutics, you can compare the effects of market volatilities on Equillium and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Checkpoint Therapeutics.
Diversification Opportunities for Equillium and Checkpoint Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Equillium and Checkpoint is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Equillium i.e., Equillium and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Equillium and Checkpoint Therapeutics
Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Checkpoint Therapeutics. In addition to that, Equillium is 2.08 times more volatile than Checkpoint Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.27 per unit of volatility. If you would invest 254.00 in Checkpoint Therapeutics on September 13, 2024 and sell it today you would earn a total of 144.00 from holding Checkpoint Therapeutics or generate 56.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 97.67% |
| Values | Daily Returns |
Equillium vs. Checkpoint Therapeutics
Performance |
| Timeline |
| Equillium |
| Checkpoint Therapeutics |
Equillium and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Checkpoint Therapeutics
The main advantage of trading using opposite Equillium and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
| Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world |